Anna Licata

Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients

Gennaro D’Amico, Linda Pasta, A. Morabito et al. · Alimentary Pharmacology & Therapeutics · 2014 · 543 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

Vincenza Calvaruso, Giuseppe Cabibbo, Irene Cacciola et al. · Gastroenterology · 2018 · 362 citations

Medicine, Infectious Diseases, Internal Medicine +16

Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease

Salvatore Petta, Stefania Ciminnisi, V. Di Marco et al. · Alimentary Pharmacology & Therapeutics · 2016 · 214 citations

Medicine, Pathology, Clinical Nutrition +15

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Giuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso et al. · Journal of Hepatology · 2019 · 205 citations

Medicine, Infectious Diseases, Pharmacology +15

Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns

Maurizio Soresi, Antonino Terranova, Anna Licata et al. · BioMed Research International · 2017 · 181 citations · Full text

Medicine, Internal Medicine, Oncology +17